The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Equine Chorionic Gonadotropin (eCG) for Injection Market Research Report 2025

Global Equine Chorionic Gonadotropin (eCG) for Injection Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1983815

No of Pages : 83

Ask Your Query
Synopsis
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. The action of eCG is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
The global Equine Chorionic Gonadotropin (eCG) for Injection market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 356 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.
North American market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection include MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Equine Chorionic Gonadotropin (eCG) for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Chorionic Gonadotropin (eCG) for Injection.
The Equine Chorionic Gonadotropin (eCG) for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Equine Chorionic Gonadotropin (eCG) for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Chorionic Gonadotropin (eCG) for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
MSD Animal Health
Ceva Santé Animale
Syntex SA
Bioveta
Ningbo Sansheng Biological Technology
Ningbo Second Hormone Factory
Chifeng Bo-en Pharmaceutical
Guangzhou Vbio-Pharma
JALLY
Ningbo Creator Animal Pharmaceutical
Segment by Type
1000 IU/Unit
5000 IU/Unit
Others
Segment by Application
Pig
Cattle
Sheep
Horse
Other Animals
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equine Chorionic Gonadotropin (eCG) for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Equine Chorionic Gonadotropin (eCG) for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Index
1 Equine Chorionic Gonadotropin (eCG) for Injection Market Overview
1.1 Product Definition
1.2 Equine Chorionic Gonadotropin (eCG) for Injection by Type
1.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value Comparison by Type (2024-2030)
1.2.2 1000 IU/Unit
1.2.3 5000 IU/Unit
1.2.4 Others
1.3 Equine Chorionic Gonadotropin (eCG) for Injection by Application
1.3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Application (2024-2030)
1.3.2 Pig
1.3.3 Cattle
1.3.4 Sheep
1.3.5 Horse
1.3.6 Other Animals
1.4 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Estimates and Forecasts
1.4.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2030
1.4.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2030
1.4.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Equine Chorionic Gonadotropin (eCG) for Injection Market Competition by Manufacturers
2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Equine Chorionic Gonadotropin (eCG) for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Product Type & Application
2.7 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Date of Enter into This Industry
2.8 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Competitive Situation and Trends
2.8.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Equine Chorionic Gonadotropin (eCG) for Injection Players Market Share by Revenue
2.8.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Scenario by Region
3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region: 2019-2030
3.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region: 2019-2024
3.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region: 2025-2030
3.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2019-2030
3.3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2019-2024
3.3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2025-2030
3.4 North America Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.4.1 North America Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2030)
3.4.3 North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.5.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2030)
3.5.3 Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2030)
3.6.3 Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.7.1 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2030)
3.7.3 Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2030)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2025-2030)
4.1.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2030)
4.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2019-2030)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2019-2024)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2025-2030)
4.2.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2019-2030)
4.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2030)
5.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
5.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2025-2030)
5.1.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2030)
5.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2019-2030)
5.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2019-2024)
5.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2025-2030)
5.2.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2019-2030)
5.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Company Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Ceva Santé Animale
6.2.1 Ceva Santé Animale Company Information
6.2.2 Ceva Santé Animale Description and Business Overview
6.2.3 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.2.5 Ceva Santé Animale Recent Developments/Updates
6.3 Syntex SA
6.3.1 Syntex SA Company Information
6.3.2 Syntex SA Description and Business Overview
6.3.3 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.3.5 Syntex SA Recent Developments/Updates
6.4 Bioveta
6.4.1 Bioveta Company Information
6.4.2 Bioveta Description and Business Overview
6.4.3 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.4.5 Bioveta Recent Developments/Updates
6.5 Ningbo Sansheng Biological Technology
6.5.1 Ningbo Sansheng Biological Technology Company Information
6.5.2 Ningbo Sansheng Biological Technology Description and Business Overview
6.5.3 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.5.5 Ningbo Sansheng Biological Technology Recent Developments/Updates
6.6 Ningbo Second Hormone Factory
6.6.1 Ningbo Second Hormone Factory Company Information
6.6.2 Ningbo Second Hormone Factory Description and Business Overview
6.6.3 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.6.5 Ningbo Second Hormone Factory Recent Developments/Updates
6.7 Chifeng Bo-en Pharmaceutical
6.7.1 Chifeng Bo-en Pharmaceutical Company Information
6.7.2 Chifeng Bo-en Pharmaceutical Description and Business Overview
6.7.3 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.7.5 Chifeng Bo-en Pharmaceutical Recent Developments/Updates
6.8 Guangzhou Vbio-Pharma
6.8.1 Guangzhou Vbio-Pharma Company Information
6.8.2 Guangzhou Vbio-Pharma Description and Business Overview
6.8.3 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.8.5 Guangzhou Vbio-Pharma Recent Developments/Updates
6.9 JALLY
6.9.1 JALLY Company Information
6.9.2 JALLY Description and Business Overview
6.9.3 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.9.5 JALLY Recent Developments/Updates
6.10 Ningbo Creator Animal Pharmaceutical
6.10.1 Ningbo Creator Animal Pharmaceutical Company Information
6.10.2 Ningbo Creator Animal Pharmaceutical Description and Business Overview
6.10.3 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolio
6.10.5 Ningbo Creator Animal Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Chorionic Gonadotropin (eCG) for Injection Industry Chain Analysis
7.2 Equine Chorionic Gonadotropin (eCG) for Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Chorionic Gonadotropin (eCG) for Injection Production Mode & Process
7.4 Equine Chorionic Gonadotropin (eCG) for Injection Sales and Marketing
7.4.1 Equine Chorionic Gonadotropin (eCG) for Injection Sales Channels
7.4.2 Equine Chorionic Gonadotropin (eCG) for Injection Distributors
7.5 Equine Chorionic Gonadotropin (eCG) for Injection Customers
8 Equine Chorionic Gonadotropin (eCG) for Injection Market Dynamics
8.1 Equine Chorionic Gonadotropin (eCG) for Injection Industry Trends
8.2 Equine Chorionic Gonadotropin (eCG) for Injection Market Drivers
8.3 Equine Chorionic Gonadotropin (eCG) for Injection Market Challenges
8.4 Equine Chorionic Gonadotropin (eCG) for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Equine Chorionic Gonadotropin (eCG) for Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Equine Chorionic Gonadotropin (eCG) for Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Product Type & Application
Table 12. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG) for Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Equine Chorionic Gonadotropin (eCG) for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Chorionic Gonadotropin (eCG) for Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2019-2024)
Table 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2025-2030)
Table 21. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Table 53. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2025-2030)
Table 54. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Table 63. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2025-2030)
Table 64. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Application (2025-2030)
Table 70. MSD Animal Health Company Information
Table 71. MSD Animal Health Description and Business Overview
Table 72. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 74. MSD Animal Health Recent Developments/Updates
Table 75. Ceva Santé Animale Company Information
Table 76. Ceva Santé Animale Description and Business Overview
Table 77. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 79. Ceva Santé Animale Recent Developments/Updates
Table 80. Syntex SA Company Information
Table 81. Syntex SA Description and Business Overview
Table 82. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 84. Syntex SA Recent Developments/Updates
Table 85. Bioveta Company Information
Table 86. Bioveta Description and Business Overview
Table 87. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 89. Bioveta Recent Developments/Updates
Table 90. Ningbo Sansheng Biological Technology Company Information
Table 91. Ningbo Sansheng Biological Technology Description and Business Overview
Table 92. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 94. Ningbo Sansheng Biological Technology Recent Developments/Updates
Table 95. Ningbo Second Hormone Factory Company Information
Table 96. Ningbo Second Hormone Factory Description and Business Overview
Table 97. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 99. Ningbo Second Hormone Factory Recent Developments/Updates
Table 100. Chifeng Bo-en Pharmaceutical Company Information
Table 101. Chifeng Bo-en Pharmaceutical Description and Business Overview
Table 102. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 104. Chifeng Bo-en Pharmaceutical Recent Developments/Updates
Table 105. Guangzhou Vbio-Pharma Company Information
Table 106. Guangzhou Vbio-Pharma Description and Business Overview
Table 107. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 109. Guangzhou Vbio-Pharma Recent Developments/Updates
Table 110. JALLY Company Information
Table 111. JALLY Description and Business Overview
Table 112. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 114. JALLY Recent Developments/Updates
Table 115. Ningbo Creator Animal Pharmaceutical Company Information
Table 116. Ningbo Creator Animal Pharmaceutical Description and Business Overview
Table 117. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product
Table 119. Ningbo Creator Animal Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Equine Chorionic Gonadotropin (eCG) for Injection Distributors List
Table 123. Equine Chorionic Gonadotropin (eCG) for Injection Customers List
Table 124. Equine Chorionic Gonadotropin (eCG) for Injection Market Trends
Table 125. Equine Chorionic Gonadotropin (eCG) for Injection Market Drivers
Table 126. Equine Chorionic Gonadotropin (eCG) for Injection Market Challenges
Table 127. Equine Chorionic Gonadotropin (eCG) for Injection Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Product Picture of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 2. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Type: 2023 & 2030
Figure 4. 1000 IU/Unit Product Picture
Figure 5. 5000 IU/Unit Product Picture
Figure 6. Others Product Picture
Figure 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Application: 2023 & 2030
Figure 9. Pig
Figure 10. Cattle
Figure 11. Sheep
Figure 12. Horse
Figure 13. Other Animals
Figure 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size (2019-2030) & (US$ Million)
Figure 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (2019-2030) & (K Units)
Figure 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Average Price (US$/Unit) & (2019-2030)
Figure 18. Equine Chorionic Gonadotropin (eCG) for Injection Report Years Considered
Figure 19. Equine Chorionic Gonadotropin (eCG) for Injection Sales Share by Manufacturers in 2023
Figure 20. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Equine Chorionic Gonadotropin (eCG) for Injection Players: Market Share by Revenue in Equine Chorionic Gonadotropin (eCG) for Injection in 2023
Figure 22. Equine Chorionic Gonadotropin (eCG) for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2030)
Figure 25. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2030)
Figure 26. United States Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2030)
Figure 29. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2030)
Figure 30. Germany Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2019-2030)
Figure 37. China Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2030)
Figure 45. Mexico Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Type (2019-2030)
Figure 56. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) for Injection by Application (2019-2030)
Figure 59. Global Equine Chorionic Gonadotropin (eCG) for Injection Price (US$/Unit) by Application (2019-2030)
Figure 60. Equine Chorionic Gonadotropin (eCG) for Injection Value Chain
Figure 61. Equine Chorionic Gonadotropin (eCG) for Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock